Arbutus Biopharma - M&A Summary and Business Overview

Life ScienceCompany

Arbutus Biopharma M&A Summary

Arbutus Biopharma has acquired 2 companies.

Arbutus Biopharma has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (50%) and medical products (50%).

Arbutus Biopharma Business Overview

Where is Arbutus Biopharma headquartered?

Arbutus Biopharma is headquartered in Warminster, Pennsylvania.

What is Arbutus Biopharma’s revenue?

Arbutus Biopharma disclosed revenue of 18M USD for 2023 and 39M USD for 2022.

How many employees does Arbutus Biopharma have?

Arbutus Biopharma has 73 employees.

What sector is Arbutus Biopharma in?

Arbutus Biopharma is a life science company.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 2

Arbutus Biopharma

Arbutus Biopharma Corp.

701 Veterans Circle,
Warminster, Pennsylvania 18974
United States,
(267) 469-0914
www.arbutusbio.com

Arbutus Biopharma is a biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). Arbutus Biopharma is based in Warminster, Pennsylvania.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 2 - - - - - 2
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
OnCore Biopharma, Inc. 2015-03-04 - Merger
Doylestown, Pennsylvania · www.oncorebiopharma.com
Protiva Biotherapeutics, Inc. 2008-05-30 - Add-on Acquisition
Burnaby, British Columbia
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (50%) - - -
Medical Products 1 (50%) - - -
Total 2 - - -

By Geo

State/Country Buy Value Sell Value
Canada 1 - - -
  British Columbia 1 - - -
United States 1 - - -
  Pennsylvania 1 - - -
Domestic 1 (50%) - - -
Cross-border 1 (50%) - - -
Total 2 - - -

 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.